Redmile Group, LLC
CIK 1425738 · Lihat di SEC EDGAR ↗
- Nilai Portofolio
- $1.5B
- Posisi
- 39
- Per tanggal
- 30 Juni 2026
#1.875 dari 9.443 berdasarkan nilai 13F · top 19.9%
Nilai portofolio QoQ: -1.4% 13F tidak mengungkapkan kas
- Bobot 10 kepemilikan teratas
- 73,48%
- Bobot 25 kepemilikan teratas
- 94,67%
- Posisi di atas 1%
- 22
- Jumlah posisi efektif
- 12,7
Berdasarkan kepemilikan ekuitas jangka panjang 13F saja (kas, obligasi, posisi jual tidak diungkapkan)
Perputaran Q2 2026: 6,68% Perkiraan pembelian $100.160.800 · penjualan $445.586.574
Kepemilikan median: 4,0 kuartal Dilacak Q4 2024–Q2 2026 · 50,6% masih dipegang
- Posisi baru
- 4
- Meningkat
- 5
- Menurun
- 23
- Tertutup
- 4
Di halaman ini
- Kinerja vs S&P Bagaimana portofolio 13F manajer ini berkinerja terhadap S&P 500.
- Rincian sektor Bagaimana portofolio terbagi di berbagai sektor pasar.
- Portofolio Setiap saham yang dilaporkan dimiliki oleh institusi ini, dari 13F terbarunya.
- Taruhan baru terbesar Posisi baru yang dibuka pada kuartal terakhir.
- Pergerakan Teratas Peningkatan dan penurunan posisi terbesar pada kuartal ini.
- Posisi yang keluar Posisi yang sepenuhnya dijual oleh manajer pada kuartal lalu.
- Terkait Orang di balik pengaju ini, jika kami dapat mencocokkannya.
Kinerja vs S&P 500
Tahunan: +44.2% · S&P 500: +18.0%
Perkiraan portofolio beli-dan-tahan yang dibangun dari snapshot 13F SEC triwulanan. Mengecualikan kas, posisi jual, opsi/derivatif, dan sekuritas non-13(f) — mencerminkan buku ekuitas long yang diungkapkan saja, bukan total AUM dana. Keterlambatan pengajuan SEC hingga 45 hari; ini bukan waktu yang dapat disalin secara real-time.
Cakupan yang dapat dihargai: 97,9% · Opsi dikecualikan: 0,0%
Rincian sektor
Healthcare
97,1%
Lainnya/Tidak terpetakan
2,9%
Portofolio lengkap 39 posisi
| Tipe | Rentetan | Tren 8 kuartal | |||||
|---|---|---|---|---|---|---|---|
| SRRK Scholar Rock Holding Corporation - Common Stock | $237.110.060 | 15,92% | 4.311.092 | $-208.605.028 | Turun ×1 | ||
| KRYS Krystal Biotech, Inc. - Common Stock | $234.897.298 | 15,77% | 632.005 | $60.917.486 | Turun ×2 | ||
| STOK Stoke Therapeutics, Inc. - Common Stock | $129.110.502 | 8,67% | 3.945.920 | $-6.473.245 | Turun ×1 | ||
| IMNM Immunome, Inc. - Common Stock | $104.076.592 | 6,99% | 4.911.590 | $-17.496.223 | Turun ×2 | ||
| NRIX Nurix Therapeutics, Inc. - Common stock | $98.830.073 | 6,64% | 4.073.787 | $-21.028.451 | Turun ×2 | ||
| ABSI Absci Corporation - Common Stock | $78.112.833 | 5,24% | 6.739.675 | $53.352.885 | Turun ×1 | ||
| ANNX Annexon, Inc. - common stock | $67.776.998 | 4,55% | 11.869.877 | $-12.828.717 | Turun ×1 | ||
| RGNX REGENXBIO Inc. - Common Stock | $52.338.272 | 3,51% | 4.368.804 | $15.727.694 | |||
| STTK Shattuck Labs, Inc. - Common Stock | $47.830.709 | 3,21% | 6.892.033 | $12.210.284 | Naik ×1 | ||
| NGNE Neurogene Inc. - Common Stock | $44.413.659 | 2,98% | 1.412.199 | $14.988.143 | Turun ×1 | ||
| BEAM Beam Therapeutics Inc. - Common Stock | $39.957.369 | 2,68% | 1.164.259 | $10.463.955 | Turun ×5 | ||
| AGMB AgomAb Therapeutics NV - ADRs representing one common share. | $35.486.359 | 2,38% | 2.733.926 | $33.847.296 | Naik ×1 | ||
| FATE Fate Therapeutics, Inc. - Common Stock | $34.756.954 | 2,33% | 12.872.946 | $19.309.419 | |||
| IDYA IDEAYA Biosciences, Inc. - Common Stock | $23.860.329 | 1,60% | 640.202 | $6.496.711 | Naik ×1 | ||
| SLN Silence Therapeutics Plc - American Depository Share | $23.769.251 | 1,60% | 2.164.777 | $12.360.876 | |||
| COGT Cogent Biosciences, Inc. - Common Stock | $19.478.523 | 1,31% | 503.321 | $-7.003.983 | Turun ×3 | ||
| SLDB Solid Biosciences Inc. - Common Stock | $19.467.463 | 1,31% | 1.948.695 | $4.981.819 | Turun ×1 | ||
| NUVB Nuvation Bio Inc. Class A Common Stock | $17.216.131 | 1,16% | 3.031.009 | $3.688.663 | Turun ×2 | ||
| CLDX Celldex Therapeutics, Inc. - Common Stock | $16.146.200 | 1,08% | 433.921 | $7.851.166 | Naik ×1 | ||
| CLYM Climb Bio, Inc. - Common Stock | $15.991.343 | 1,07% | 1.226.330 | Naik ×1 | |||
| ALXO ALX Oncology Holdings Inc. - Common Stock | $15.302.483 | 1,03% | 7.392.504 | $-665.714 | Turun ×1 | ||
| BMRN BioMarin Pharmaceutical Inc. - Common Stock | $15.172.970 | 1,02% | 265.169 | $5.351.675 | Naik ×1 | ||
| XENE Xenon Pharmaceuticals Inc. - Common Shares | $13.845.015 | 0,93% | 229.374 | $-1.429.478 | Turun ×1 | ||
| ZYME Zymeworks Inc. - Common Stock | $12.851.836 | 0,86% | 491.654 | $540.820 | |||
| ADCT ADC Therapeutics SA Common Shares | $12.333.580 | 0,83% | 11.526.710 | $-45.680.803 | Turun ×2 | ||
| AURA Aura Biosciences, Inc. - Common Stock | $11.833.336 | 0,79% | 1.666.667 | Naik ×1 | |||
| Penerbit tidak dikenal (CUSIP: 67613T104) | $7.951.750 | 0,53% | 425.000 | Naik ×1 | |||
| LIVN LivaNova PLC - Ordinary Shares | $7.660.053 | 0,51% | 93.154 | $773.073 | Turun ×6 | ||
| ESTA Establishment Labs Holdings Inc. - Common Shares | $7.634.001 | 0,51% | 88.964 | $1.759.315 | Turun ×5 | ||
| CBLL CeriBell, Inc. - Common Stock | $7.522.988 | 0,51% | 386.786 | $433.201 | |||
| DBVT DBV Technologies S.A. - American Depositary Shares | $6.731.216 | 0,45% | 410.440 | $-3.532.877 | Turun ×2 | ||
| INSM Insmed Incorporated - Common Stock | $5.462.569 | 0,37% | 51.234 | Naik ×1 | |||
| PRME Prime Medicine, Inc. - Common Stock | $5.127.742 | 0,34% | 1.389.632 | $-408.353 | Turun ×1 | ||
| ATRA Atara Biotherapeutics, Inc. - Common Stock | $5.070.727 | 0,34% | 441.701 | $2.981.481 | |||
| EPRX Eupraxia Pharmaceuticals Inc. - Common Stock | $4.041.354 | 0,27% | 611.400 | $-1.026.646 | Turun ×1 | ||
| ORIC Oric Pharmaceuticals, Inc. - Common Stock | $3.920.568 | 0,26% | 362.010 | $-1.346.478 | Turun ×2 | ||
| ARDX Ardelyx, Inc. - Common Stock | $3.272.925 | 0,22% | 641.750 | $-1.119.842 | Turun ×1 | ||
| IVVD Invivyd, Inc. - Common Stock | $2.266.285 | 0,15% | 2.597.759 | $-1.176.972 | Turun ×2 | ||
| PLRX Pliant Therapeutics, Inc. - Common Stock | $880.224 | 0,06% | 772.126 | $-92.655 | |||
| Tidak ada hasil | |||||||
Taruhan baru terbesar
Posisi baru dibuka kuartal ini, terbesar diurutkan pertama.
Penggerak teratas (QoQ)
| Sekuritas | Aksi | Saham Δ | Nilai Δ |
|---|---|---|---|
| SRRK | Dipangkas | -4.8M | -$208.6M |
| KRYS | Dipangkas | -42K | +$60.9M |
| ABSI | Dipangkas | -1.5M | +$53.4M |
| ADCT | Dipangkas | -3.9M | -$45.7M |
| NRIX | Dipangkas | -3.7M | -$21.0M |
| FATE | Hanya pergerakan harga | +0 | +$19.3M |
| IMNM | Dipangkas | -647K | -$17.5M |
| RGNX | Hanya pergerakan harga | +0 | +$15.7M |
| NGNE | Dipangkas | -47K | +$15.0M |
| ANNX | Dipangkas | -2.7M | -$12.8M |
1 posisi disembunyikan (pemeriksaan kelengkapan data)
Posisi yang keluar
Termasuk peristiwa perusahaan (merger, delisting) — tidak semua keluar adalah penjualan
Posisi tertutup mencerminkan perubahan pelaporan 13F; bagi manajer indeks, ini sering kali mekanis (penghapusan pencatatan, M&A, penyeimbangan ulang indeks), bukan keputusan aktif.
| Sekuritas | Kuartal | Saham sebelumnya | Nilai sebelumnya | Harga sejak keluar |
|---|---|---|---|---|
| AKRO | 31 Des. 2025 | 747.818 | $35.506.399 | Tidak lagi dilacak |
| KYMR | 30 Sep. 2025 | 803.289 | $35.055.532 | 119,7% |
| RAPT | 31 Maret 2026 | 885.927 | $30.006.347 | Tidak lagi dilacak |
| ETNB | 31 Des. 2025 | 1.473.136 | $21.655.099 | Tidak lagi dilacak |
| HNGE | 30 Sep. 2025 | 300.000 | $15.525.000 | 80,6% |
| SYK | 31 Maret 2025 | 30.676 | $11.044.894 | -8,7% |
| REPL | 31 Maret 2026 | 1.099.756 | $10.689.628 | 86,3% |
| BHVN | 30 Sep. 2025 | 729.515 | $10.293.457 | -7,4% |
| BSX | 30 Sep. 2025 | 85.301 | $9.162.180 | -47,3% |
| ISRG | 31 Maret 2025 | 16.943 | $8.843.568 | -20,3% |
| KROS | 31 Des. 2025 | 552.506 | $8.740.645 | -47,1% |
| IMVT | 30 Juni 2025 | 490.394 | $8.380.833 | 176,7% |
| VERV | 30 Sep. 2025 | 740.261 | $8.313.131 | Tidak lagi dilacak |
| ARDX | 31 Maret 2025 | 1.576.259 | $7.991.633 | -18,0% |
| PODD | 30 Juni 2025 | 27.109 | $7.119.094 | -51,7% |
| BNTX | 30 Juni 2025 | 73.071 | $6.653.845 | 1,9% |
| FOLD | 31 Des. 2025 | 777.178 | $6.124.163 | Tidak lagi dilacak |
| IRTC | 30 Juni 2025 | 56.844 | $5.950.430 | -18,0% |
| PEN | 30 Sep. 2025 | 18.818 | $4.829.263 | 29,0% |
| MASI | 30 Juni 2025 | 26.062 | $4.341.929 | Tidak lagi dilacak |
| RPTX | 31 Maret 2026 | 1.586.174 | $4.124.052 | Tidak lagi dilacak |
| STXS | 31 Maret 2025 | 1.799.465 | $4.102.780 | Tidak lagi dilacak |
| ORKA | 30 Juni 2025 | 386.963 | $3.970.240 | 854,5% |
| XERS | 31 Des. 2025 | 451.099 | $3.671.946 | 13,8% |
| VTYX | 31 Des. 2025 | 1.073.386 | $3.338.230 | Tidak lagi dilacak |
| IGMS | 30 Sep. 2025 | 2.952.131 | $3.306.387 | Tidak lagi dilacak |
| CYTK | 30 Juni 2025 | 82.098 | $3.299.519 | 131,7% |
| LVTX | 31 Des. 2025 | 2.074.372 | $3.236.020 | Tidak lagi dilacak |
| ACIU | 31 Maret 2025 | 1.034.299 | $2.792.607 | 35,2% |
| ACHL | 31 Maret 2025 | 1.608.089 | $1.833.221 | Tidak lagi dilacak |
| ATXS | 30 Juni 2025 | 269.078 | $1.436.877 | Tidak lagi dilacak |
| ALVR | 31 Maret 2025 | 1.907.969 | $801.347 | Tidak lagi dilacak |
| KLRS | 31 Maret 2026 | 82.955 | $700.140 | -27,2% |
| PRME | 31 Des. 2025 | 87.118 | $482.634 | -2,0% |
| FDMT | 30 Sep. 2025 | 112.168 | $416.143 | 80,7% |
| ADAPY | 31 Maret 2025 | 715.607 | $385.497 | Tidak lagi dilacak |
| BOLD | 31 Des. 2025 | 245.458 | $301.913 | 140,8% |
| HOOK | 31 Maret 2025 | 106.376 | $213.816 | Tidak lagi dilacak |
| ALLK | 30 Juni 2025 | 856.615 | $194.966 | Tidak lagi dilacak |